Report Overview

According to the deep-dive market assessment study by Growth Plus Reports, the global Bronchoscopes market was valued at US$ 3.20 billion in 2022 and is expected to register a revenue CAGR of 7.5% to reach US$ 6.13 billion by 2031.

Bronchoscopes Market Fundamentals

Bronchoscopes are medical devices used for visualizing the inside of the airways in the lungs. They are slender, flexible, or rigid tubes equipped with a light source and a camera or fiber-optic system that allows physicians to examine the bronchial tubes and surrounding structures. Bronchoscopes are commonly used for diagnostic and therapeutic purposes. They can help identify and evaluate conditions such as lung infections, tumors, inflammation, or other abnormalities within the respiratory system. The images captured by the bronchoscope can be viewed in real-time on a monitor, allowing doctors to make accurate assessments and guide their interventions. Bronchoscopes may also have additional features, such as channels for inserting tiny surgical instruments or tools to collect tissue samples (biopsies) for further analysis. These instruments allow doctors to perform various procedures during bronchoscopy, including removing foreign objects, treating bleeding, dilating narrow airways, or delivering medication directly to specific areas of the lungs.

Bronchoscopes Market Dynamics

The rising prevalence of respiratory diseases, such as lung cancer, chronic obstructive pulmonary disease (COPD), asthma, and bronchitis, are significant drivers for the bronchoscope market. As the global burden of these diseases continues to grow, the demand for bronchoscopes for diagnosis, staging, and treatment monitoring also increases. According to the FIRS Global Impact of Respiratory Disease report, COPD affects an estimated 200 million people, with 3.2 million deaths yearly, making it the third-leading cause of death worldwide. Technological advancements have significantly improved bronchoscope capabilities, enhancing their diagnostic and therapeutic capabilities. The development of high-definition imaging, improved optical systems, and video processing technologies have enabled better visualization and detection of abnormalities in the airways. Additionally, integrating additional features like navigational systems, ultrasound probes, and advanced biopsy tools has increased the bronchoscopes market demand. There is a growing preference for minimally invasive procedures in the medical field. Bronchoscopy offers a less invasive alternative to traditional surgical interventions, allowing for diagnostic and therapeutic procedures to be performed with fewer complications, reduced recovery times, and improved patient outcomes. This bronchoscopes industry trend toward minimally invasive procedures has driven the demand for bronchoscopes. The growing geriatric population, especially in developed countries, has emerged as a significant demographic factor driving the growth of the bronchoscope market. As elderly individuals are more prone to respiratory diseases, such as lung cancer and COPD, the demand for bronchoscopy procedures has surged. According to the World Health Organization, the number of individuals aged 60 and more is predicted to double from 900 million in 2015 to 2 billion by 2050. There is a growing emphasis on screening programs, awareness campaigns, and initiatives to promote early detection of lung cancer, COPD, and other respiratory conditions. Bronchoscopy plays a crucial role in early diagnosis through techniques like bronchoalveolar lavage, transbronchial biopsy, and endobronchial ultrasound-guided biopsy. According to the WHO, in 2020, around 2.21 million cases of lung cancer were diagnosed globally.

However, bronchoscopy procedures are expensive due to the cost of the equipment, disposables, and associated healthcare services. The high cost is limiting accessibility, particularly in regions with limited healthcare resources or where reimbursement coverage is inadequate, this is hindering the bronchoscopes market growth. There is a potential for complications such as bleeding, pneumothorax, infection, or adverse reactions to anesthesia or sedation during bronchoscopy procedures. Concerns regarding these risks can influence patient acceptance, which is also restricting the bronchoscopesmarket growth.

Bronchoscopes Market Ecosystem

The global bronchoscopes market is analyzed from three perspectives: usage, type, and region. 

Bronchoscopes Market by Usage

Based on the usage, the global bronchoscopes market is segmented into reusable and disposable.

The reusable segment accounted for the largest bronchoscopes market share in 2022. Reusable bronchoscopes offer cost advantages over their disposable counterparts in the long run. While the initial purchase cost of reusable bronchoscopes may be higher, they can be used for multiple procedures, reducing the need for frequent repurchases. Many healthcare facilities already have established infrastructure and processes for reprocessing and sterilizing reusable bronchoscopes. This infrastructure includes dedicated reprocessing areas, trained staff, and adherence to standardized reprocessing protocols. Reusable bronchoscopes often provide more options for customization and flexibility. They come in a variety of sizes and specifications, allowing healthcare professionals to choose the most suitable bronchoscope for their specific needs. This versatility and customization enable better adaptability to diverse patient populations and procedure requirements. Healthcare professionals, especially experienced bronchoscopists, are often more familiar with and have extensive training and experience with reusable bronchoscopes. They are accustomed to the handling, performing, and maintaining these devices.

The disposable segment accounted for a considerable revenue share of the bronchoscopes market. Disposable bronchoscopes offer a significant advantage in terms of infection control. These single-use devices eliminate the risk of cross-contamination between patients as they are used once and then discarded. In settings where infection prevention is a top priority, such as in high-risk or infectious disease cases, disposable bronchoscopes are preferred to minimize the risk of transmitting infections. Disposable bronchoscopes offer convenience and time efficiency compared to reusable devices. They eliminate the need for reprocessing and sterilization after each use, reducing turnaround time between procedures. Reusable bronchoscopes may experience technical failures, such as deterioration in image quality or mechanical issues, over time with repeated use. Disposable bronchoscopes, on the other hand, ensure consistent performance and avoid the potential for device-related failures or deterioration. The COVID-19 pandemic has led to an increased demand for disposable bronchoscopes. The need for infection control and reducing the risk of virus transmission has driven the preference for single-use devices, including bronchoscopes. Healthcare facilities have prioritized disposable options to ensure the safety of both patients and healthcare providers during bronchoscopy procedures.

Bronchoscopes Market by Type 

Based on the types, the global bronchoscopes market is segmented into rigid and flexible.

The flexible segment accounted for a significant revenue share of the bronchoscopes market in 2022. Flexible bronchoscopes offer superior maneuverability compared to rigid bronchoscopes. Their flexible shafts allow for easier navigation through the intricate and branching airways, enabling healthcare professionals to reach distant locations and visualize hard-to-reach areas within the respiratory system. This enhanced maneuverability is particularly advantageous in complex cases or when accessing peripheral lung regions. Flexible bronchoscopes are generally more comfortable for patients compared to rigid bronchoscopes. The instrument’s flexibility allows for smoother insertion and minimizes discomfort during the procedure. Flexible bronchoscopy is considered a minimally invasive procedure as it does not require surgical incisions. It is performed through natural body openings, such as the mouth or nose, without needing external access points. Flexible bronchoscopes are versatile instruments capable of performing various diagnostic and therapeutic procedures. They can be equipped with additional channels for biopsy, suction, and therapeutic tools, allowing for various interventions such as biopsy sampling, bronchoalveolar lavage, foreign body retrieval, and bronchial stenting. Flexible bronchoscopes are equipped with advanced imaging technologies, such as high-definition cameras and optical enhancements. These imaging capabilities provide clear and detailed visualization of the airways, facilitating accurate diagnosis and guiding therapeutic interventions.

Bronchoscopes Market by Region

Geographically, the global bronchoscopes market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. 

The North America region has the largest bronchoscopes market size in terms of revenue generation accounting for around 34.6% share of the market. North America has a significant burden of respiratory diseases, including lung cancer, chronic obstructive pulmonary disease (COPD), and asthma. The high prevalence of these conditions creates a substantial demand for bronchoscopy procedures as an essential diagnostic and therapeutic tool for accurate disease assessment, staging, and treatment planning. According to the American Lung Association, in 2020, 12.5 million people, or 5.0% of adults in the U.S., were diagnosed with COPD. There is an increasing emphasis on early detection and screening programs for respiratory diseases in North America. Initiatives like lung cancer screening programs, which utilize bronchoscopy for early detection of lung cancer in high-risk populations, contribute to the demand for bronchoscopes. North America is at the forefront of technological advancements, including the development of advanced imaging technologies for bronchoscopy. High-definition imaging systems, endobronchial ultrasound (EBUS), navigational bronchoscopy, and virtual bronchoscopy have significantly improved visualization and diagnostic accuracy. North America boasts a robust healthcare infrastructure with well-equipped hospitals, specialized respiratory care centers, and skilled healthcare professionals. The availability of advanced facilities and a highly trained workforce supports the adoption and utilization of bronchoscopes for respiratory disease management.

Bronchoscopes Market Competitive Landscape

The prominent players operating in the global bronchoscopesmarket are:

• Olympus Corporation
• Karl Storz SE & Co. KG
• Teleflex Incorporated
• Boston Scientific Corporation
• Fujifilm Holdings Corporation
• Ambu A/S
• Richard Wolf GmbH 
• HOYA Corporation
• CONMED Corporation
• Ethicon, Inc. (Johnson & Johnson)

Bronchoscopes Market Strategic Developments

• In March 2023, Noah Medical received FDA approval for the Galaxy System. The Galaxy System and its accessories are intended to provide bronchoscopic visualization of and access to patient airways for diagnostic and therapeutic procedures. The Galaxy System incorporates TiLT+ Technology, which includes integrated tomosynthesis and augmented fluoroscopy. With its always-on-camera bronchoscope, direct visualization is possible throughout the procedure, including during biopsy.
• In July 2022, Ambu Inc. received 510(k) regulatory clearance from FDA for Ambu aScopeTM 5 Broncho, a family of single-use, sterile bronchoscopes. Ambu's fifth-generation bronchoscope is sterile and consistently performs well, putting patient safety at the forefront of every procedure. Furthermore, Ambu's solution is an appealing choice for health care providers who need to perform bronchoscopies due to its advanced technology, portability, and cost-effectiveness.

Frequently Asked Questions About This Report